Variation in Cilia Protein Genes and Progression of Lung Disease in Cystic Fibrosis
暂无分享,去创建一个
R. Gibson | M. Bamshad | M. Emond | K. Barnes | T. Louie | S. Hebbring | J. Chong | E. Blue | N. Rafaels | M. Knowles | Jessica X. Chong
[1] Michael J Bamshad,et al. Guidelines for Large-Scale Sequence-Based Complex Trait Association Studies: Lessons Learned from the NHLBI Exome Sequencing Project. , 2016, American journal of human genetics.
[2] Katsushi Tokunaga,et al. Phenome-wide association study maps new diseases to the human major histocompatibility complex region , 2016, Journal of Medical Genetics.
[3] Brian T. Naughton,et al. Analysis of 589,306 genomes identifies individuals resilient to severe Mendelian childhood diseases , 2016, Nature Biotechnology.
[4] S. Dutcher,et al. Genetics and biology of primary ciliary dyskinesia. , 2016, Paediatric respiratory reviews.
[5] L. Morgan,et al. The impact of Primary Ciliary Dyskinesia on the upper respiratory tract. , 2016, Paediatric respiratory reviews.
[6] M. Dransfield,et al. Acquired Cystic Fibrosis Transmembrane Conductance Regulator Dysfunction in Chronic Bronchitis and Other Diseases of Mucus Clearance. , 2016, Clinics in chest medicine.
[7] M. Moustaki,et al. Clinical spectrum of primary ciliary dyskinesia in childhood. , 2016, World journal of clinical pediatrics.
[8] L. Leatherbury,et al. DNAH6 and Its Interactions with PCD Genes in Heterotaxy and Primary Ciliary Dyskinesia , 2016, PLoS genetics.
[9] M. Brodlie,et al. Airway surface liquid homeostasis in cystic fibrosis: pathophysiology and therapeutic targets , 2015, Thorax.
[10] Eric J. Topol,et al. Protective alleles and modifier variants in human health and disease , 2015, Nature Reviews Genetics.
[11] J. Rommens,et al. Genome-wide association meta-analysis identifies five modifier loci of lung disease severity in cystic fibrosis , 2015, Nature Communications.
[12] Andrew J. Oler,et al. Pulmonary Nontuberculous Mycobacterial Infection. A Multisystem, Multigenic Disease. , 2015, American journal of respiratory and critical care medicine.
[13] Simon Lin,et al. Application of clinical text data for phenome-wide association studies (PheWASs) , 2015, Bioinform..
[14] M. Rieder,et al. Exome Sequencing of Phenotypic Extremes Identifies CAV2 and TMC6 as Interacting Modifiers of Chronic Pseudomonas aeruginosa Infection in Cystic Fibrosis , 2015, PLoS genetics.
[15] Zhan Ye,et al. Phenome-wide association studies (PheWASs) for functional variants , 2014, European Journal of Human Genetics.
[16] Richard B. Vallee,et al. Control of cytoplasmic dynein force production and processivity by its C-terminal domain , 2015, Nature Communications.
[17] M. Rosenfeld,et al. Clinical features of childhood primary ciliary dyskinesia by genotype and ultrastructural phenotype. , 2015, American journal of respiratory and critical care medicine.
[18] D. Meyerholz,et al. Origins of cystic fibrosis lung disease. , 2015, The New England journal of medicine.
[19] D. Meyerholz,et al. Origins of cystic fibrosis lung disease. , 2015, The New England journal of medicine.
[20] Garry R. Cutting,et al. Cystic fibrosis genetics: from molecular understanding to clinical application , 2014, Nature Reviews Genetics.
[21] E. Hoffman,et al. Impaired mucus detachment disrupts mucociliary transport in a piglet model of cystic fibrosis , 2014, Science.
[22] G. Abecasis,et al. Rare-variant association analysis: study designs and statistical tests. , 2014, American journal of human genetics.
[23] J. Shendure,et al. A general framework for estimating the relative pathogenicity of human genetic variants , 2014, Nature Genetics.
[24] S. Brody,et al. Picking up speed: advances in the genetics of primary ciliary dyskinesia , 2013, Pediatric Research.
[25] Richard D Emes,et al. Combined exome and whole-genome sequencing identifies mutations in ARMC4 as a cause of primary ciliary dyskinesia with defects in the outer dynein arm , 2013, Journal of Medical Genetics.
[26] L. A. Daniels,et al. Primary ciliary dyskinesia. Recent advances in diagnostics, genetics, and characterization of clinical disease. , 2013, American journal of respiratory and critical care medicine.
[27] Emily H Turner,et al. Mutations in SPAG1 cause primary ciliary dyskinesia associated with defective outer and inner dynein arms. , 2013, American journal of human genetics.
[28] M. Rosenfeld,et al. Zebrafish Ciliopathy Screen Plus Human Mutational Analysis Identifies C21orf59 and CCDC65 Defects as Causing Primary Ciliary Dyskinesia. , 2013, American journal of human genetics.
[29] H. Omran,et al. DYX1C1 is required for axonemal dynein assembly and ciliary motility , 2013, Nature Genetics.
[30] Kate S. Wilson,et al. CCDC65 Mutation Causes Primary Ciliary Dyskinesia with Normal Ultrastructure and Hyperkinetic Cilia , 2013, PloS one.
[31] J. Lupski,et al. ARMC4 mutations cause primary ciliary dyskinesia with randomization of left/right body asymmetry. , 2013, American journal of human genetics.
[32] M. Rosenfeld,et al. ZMYND10 is mutated in primary ciliary dyskinesia and interacts with LRRC6. , 2013, American journal of human genetics.
[33] A. Gaggar,et al. Acquired cystic fibrosis transmembrane conductance regulator dysfunction in the lower airways in COPD. , 2013, Chest.
[34] Ivana V. Yang,et al. Expression of cilium-associated genes defines novel molecular subtypes of idiopathic pulmonary fibrosis , 2013, Thorax.
[35] L. Clarke,et al. Changes in transcriptome of native nasal epithelium expressing F508del-CFTR and intersecting data from comparable studies , 2013, Respiratory Research.
[36] B. Kerem,et al. LRRC6 Mutation Causes Primary Ciliary Dyskinesia with Dynein Arm Defects , 2013, PloS one.
[37] M. Rosenfeld,et al. Mutations in CCDC39 and CCDC40 are the Major Cause of Primary Ciliary Dyskinesia with Axonemal Disorganization and Absent Inner Dynein Arms , 2013, Human mutation.
[38] M. Drumm,et al. Genetic Influences on Cystic Fibrosis Lung Disease Severity , 2013, Front. Pharmacol..
[39] Kenny Q. Ye,et al. An integrated map of genetic variation from 1,092 human genomes , 2012, Nature.
[40] M. Rieder,et al. Optimal unified approach for rare-variant association testing with application to small-sample case-control whole-exome sequencing studies. , 2012, American journal of human genetics.
[41] M. Rieder,et al. Exome sequencing of extreme phenotypes identifies DCTN4 as a modifier of chronic Pseudomonas aeruginosa infection in cystic fibrosis , 2012, Nature Genetics.
[42] A. Schier,et al. CCDC103 mutations cause primary ciliary dyskinesia by disrupting assembly of ciliary dynein arms , 2012, Nature Genetics.
[43] H. Mussaffi,et al. Mutations in axonemal dynein assembly factor DNAAF3 cause primary ciliary dyskinesia , 2012, Nature Genetics.
[44] Stacey S. Cherny,et al. Evaluating the effective numbers of independent tests and significant p-value thresholds in commercial genotyping arrays and public imputation reference datasets , 2011, Human Genetics.
[45] M. Corey,et al. A novel lung disease phenotype adjusted for mortality attrition for cystic fibrosis Genetic modifier studies , 2011, Pediatric pulmonology.
[46] Fred A. Wright,et al. Genome-wide association and linkage identify modifier loci of lung disease severity in cystic fibrosis at 11p13 and 20q13.2 , 2011, Nature Genetics.
[47] J. Berg,et al. Next generation massively parallel sequencing of targeted exomes to identify genetic mutations in primary ciliary dyskinesia: Implications for application to clinical testing , 2011, Genetics in Medicine.
[48] Daniel Rios,et al. Bioinformatics Applications Note Databases and Ontologies Deriving the Consequences of Genomic Variants with the Ensembl Api and Snp Effect Predictor , 2022 .
[49] P. Bork,et al. A method and server for predicting damaging missense mutations , 2010, Nature Methods.
[50] Margaret Rosenfeld,et al. Early anti-pseudomonal acquisition in young patients with cystic fibrosis: rationale and design of the EPIC clinical trial and observational study'. , 2009, Contemporary clinical trials.
[51] S. Henikoff,et al. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm , 2009, Nature Protocols.
[52] Manuel A. R. Ferreira,et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.
[53] T. Corcoran,et al. Mucociliary clearance as an outcome measure for cystic fibrosis clinical research. , 2007, Proceedings of the American Thoracic Society.
[54] D. Reich,et al. Population Structure and Eigenanalysis , 2006, PLoS genetics.
[55] E. Fisher,et al. Genetic Analysis of the Cytoplasmic Dynein Subunit Families , 2006, PLoS genetics.
[56] C. McCarty,et al. Marshfield Clinic Personalized Medicine Research Project (PMRP): design, methods and recruitment for a large population-based biobank. , 2005, Personalized medicine.
[57] Michael R Knowles,et al. Genetic modifiers of lung disease in cystic fibrosis. , 2005, The New England journal of medicine.
[58] Jonathan D. Campbell,et al. Disease-specific reference equations for lung function in patients with cystic fibrosis. , 2005, American journal of respiratory and critical care medicine.
[59] S. Batzoglou,et al. Distribution and intensity of constraint in mammalian genomic sequence. , 2005, Genome research.
[60] G. Pazour,et al. Identification of predicted human outer dynein arm genes: candidates for primary ciliary dyskinesia genes , 2005, Journal of Medical Genetics.
[61] Hitoshi Sakakibara,et al. Recent progress in dynein structure and mechanism. , 2005, Current opinion in cell biology.
[62] R. Gibson,et al. Pathophysiology and management of pulmonary infections in cystic fibrosis. , 2003, American journal of respiratory and critical care medicine.
[63] A. Togias,et al. Mutation in the gene responsible for cystic fibrosis and predisposition to chronic rhinosinusitis in the general population. , 2000, JAMA.
[64] I. Mackay,et al. Chronic sinusitis in cystic fibrosis. , 1994, Journal of the Royal Society of Medicine.